Stock listing
923818 Stock Price, News, Filings & Events — United Therapeutics Corporation
Selected listing: 923818 · LSX · EUR · DE
This page tracks United Therapeutics Corporation's 923818:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 923818:LSX. 923818:LSX is the stock-level entry point for investors researching United Therapeutics Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- 923818:LSX
- Asset type
- Stock
- Market cap
- $22.11B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LSX
- Currency
- EUR
United Therapeutics Corporation 923818:LSX stock context
This page tracks United Therapeutics Corporation's 923818:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 923818:LSX. 923818:LSX is the stock-level entry point for investors researching United Therapeutics Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from United Therapeutics Corporation
United Therapeutics Corporation Announces Participation at Upcoming Investor Conferences
September 1, 2026
United Therapeutics Presents Data at The European Society of Cardiology Congress 2026 and The European Respiratory Society International ...
August 28, 2026
United Therapeutics Corporation Announces FDA Filing Acceptance of New Drug Application for Ralinepag to Treat Pulmonary Arterial Hyperte...
August 24, 2026
United Therapeutics Corporation Reports Second Quarter 2026 Financial Results
August 5, 2026
FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across met...
July 31, 2026
United Therapeutics Corporation earnings calls
United Therapeutics Corporation (UTHR) Q2 2026 Earnings Call
August 5, 2026 · Replay with transcript and chapters
United Therapeutics Corporation (UTHR) Q1 2026 Earnings Call
May 6, 2026 · Replay with transcript and chapters
United Therapeutics Corporation (UTHR) Q4 2025 Earnings Call
February 25, 2026 · Replay with transcript and chapters
United Therapeutics Corporation (UTHR) Q3 2025 Earnings Call
October 29, 2025 · Replay with transcript and chapters
United Therapeutics Corporation (UTHR) Q2 2025 Earnings Call
July 30, 2025 · Replay with transcript and chapters
United Therapeutics Corporation (UTHR) Q1 2025 Earnings Call
April 30, 2025 · Replay with transcript and chapters
Research United Therapeutics Corporation
United Therapeutics Corporation investor report
Review AI stock analysis and investor report context for 923818:LSX.
United Therapeutics Corporation company profile
View the public company page for United Therapeutics Corporation on 6ix.
United Therapeutics Corporation news
Read company news and market updates connected to United Therapeutics Corporation.
United Therapeutics Corporation investor events
Find investor webinars, events, and replay context for United Therapeutics Corporation.
Alternate listings
UTHR:NASDAQ
US · USD
Alternate listing for United Therapeutics Corporation; the primary context on this page is 923818:LSX.
UTH:GETTEX
DE · EUR
Alternate listing for United Therapeutics Corporation; the primary context on this page is 923818:LSX.
923818:LS
DE · EUR
Alternate listing for United Therapeutics Corporation; the primary context on this page is 923818:LSX.
UTHR:BMV
MX · MXN
Alternate listing for United Therapeutics Corporation; the primary context on this page is 923818:LSX.
UTH:TRADEGATE
DE · EUR
Alternate listing for United Therapeutics Corporation; the primary context on this page is 923818:LSX.
U2TH34:BMFBOVESPA
BR · BRL
Alternate listing for United Therapeutics Corporation; the primary context on this page is 923818:LSX.
UTH:FWB
DE · EUR
Alternate listing for United Therapeutics Corporation; the primary context on this page is 923818:LSX.
UTH:MUN
DE · EUR
Alternate listing for United Therapeutics Corporation; the primary context on this page is 923818:LSX.
UTHR:BIVA
MX · MXN
Alternate listing for United Therapeutics Corporation; the primary context on this page is 923818:LSX.
UTHR:BOATS
US · USD
Alternate listing for United Therapeutics Corporation; the primary context on this page is 923818:LSX.
UTH:BX
CH · CHF
Alternate listing for United Therapeutics Corporation; the primary context on this page is 923818:LSX.
UTH:DUS
DE · EUR
Alternate listing for United Therapeutics Corporation; the primary context on this page is 923818:LSX.